Eli Lilly Income Statement (2009-2026) | LLY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	6.74B	6.77B	8.00B	7.81B	6.49B	6.94B	7.30B	6.96B	8.31B	9.50B	9.35B	8.77B	11.30B	11.44B	13.53B	12.73B	15.56B	17.60B	19.29B	19.80B
Cost of Revenue (Quarter)	1.95B	1.43B	2.05B	2.07B	1.43B	1.58B	1.55B	1.63B	1.81B	1.86B	1.79B	1.67B	2.17B	2.17B	2.40B	2.23B	2.45B	3.01B	3.37B	3.58B
Gross Profit (Quarter)	4.79B	5.34B	5.95B	5.74B	5.06B	5.36B	5.75B	5.33B	6.50B	7.64B	7.57B	7.09B	9.13B	9.27B	11.13B	10.50B	13.11B	14.59B	15.92B	16.22B
Operating items
Research & Development (Quarter)	1.66B	1.71B	1.90B	1.61B	1.78B	1.80B	2.00B	1.99B	2.36B	2.41B	2.56B	2.52B	2.71B	2.73B	3.02B	2.73B	3.34B	3.47B	3.80B	3.51B
Selling, General & Administrative (Quarter)	1.69B	1.58B	1.59B	1.56B	1.63B	1.61B	1.64B	1.75B	1.93B	1.80B	1.93B	1.95B	2.12B	2.10B	2.42B	2.47B	2.75B	2.74B	3.13B	2.93B
Restructuring Costs (Quarter)			0.10B			0.21B	0.04B				0.07B		0.43B	0.08B	0.34B	0.04B		0.36B	0.08B	0.28B
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	3.34B	3.28B	3.59B	3.17B	3.41B	3.62B	3.68B	3.73B	4.28B	4.21B	4.56B	4.47B	5.26B	4.92B	5.79B	5.24B	6.09B	6.57B	7.02B	6.72B
Operating Income (Quarter)	1.45B	2.06B	2.35B	2.57B	1.65B	1.74B	2.08B	1.60B	2.22B	3.43B	3.01B	2.62B	3.87B	4.35B	5.34B	5.27B	7.02B	8.02B	8.90B	9.50B
EBIT (Quarter)	1.45B	2.06B	2.35B	2.57B	1.65B	1.74B	2.08B	1.60B	2.22B	3.43B	3.01B	2.62B	3.87B	4.35B	5.34B	5.27B	7.02B	8.02B	8.90B	9.50B
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)	0.19B	-0.64B	-0.08B	-0.35B	-0.12B	-0.11B	0.26B	0.04B	-0.04B	-0.02B	0.12B	0.03B	-0.20B	0.06B	-0.11B	-0.24B	-0.09B	-0.13B	-0.11B	-0.07B
Net income details
EBT (Quarter)	1.59B	1.25B	1.84B	2.05B	1.09B	1.57B	2.10B	1.53B	2.09B	0.43B	2.51B	2.54B	3.52B	1.59B	5.04B	3.46B	6.78B	7.23B	8.27B	8.85B
Tax Provisions (Quarter)	0.20B	0.14B	0.11B	0.15B	0.14B	0.11B	0.16B	0.18B	0.33B	0.48B	0.32B	0.29B	0.55B	0.62B	0.63B	0.70B	1.12B	1.65B	1.63B	1.45B
Profit After Tax (Quarter)	1.39B	1.11B	1.73B	1.90B	0.95B	1.45B	1.94B	1.34B	1.76B	-0.06B	2.19B	2.24B	2.97B	0.97B	4.41B	2.76B	5.66B	5.58B	6.64B	7.40B
Net Income - Minority (Quarter)
Income from Continuing Operations (Quarter)	1.39B	1.11B	1.73B	1.90B	0.95B	1.45B	1.94B	1.34B	1.76B	-0.06B	2.19B	2.24B	2.97B	0.97B	4.41B	2.76B	5.66B	5.58B	6.64B	7.40B
Consolidated Net Income (Quarter)	1.39B	1.11B	1.73B	1.90B	0.95B	1.45B	1.94B	1.34B	1.76B	-0.06B	2.19B	2.24B	2.97B	0.97B	4.41B	2.76B	5.66B	5.58B	6.64B	7.40B
Income towards Parent Company (Quarter)	1.39B	1.11B	1.73B	1.90B	0.95B	1.45B	1.94B	1.34B	1.76B	-0.06B	2.19B	2.24B	2.97B	0.97B	4.41B	2.76B	5.66B	5.58B	6.64B	7.40B
Net Income towards Common Stockholders (Quarter)	1.39B	1.11B	1.73B	1.90B	0.95B	1.45B	1.94B	1.34B	1.76B	-0.06B	2.19B	2.24B	2.97B	0.97B	4.41B	2.76B	5.66B	5.58B	6.64B	7.40B
Additional items
EPS (Basic) (Quarter)	1.53	1.22	1.90	2.11	1.06	1.61	2.15	1.49	1.96	-0.06	2.43	2.49	3.29	1.08	4.90	3.07	6.30	6.22	7.40	8.27
EPS (Weighted Average and Diluted) (Quarter)	1.53	1.22	1.89	2.10	1.05	1.61	2.14	1.49	1.95	-0.06	2.42	2.48	3.28	1.07	4.88	3.06	6.29	6.21	7.39	8.26
Shares Outstanding (Weighted Average) (Quarter)	0.91B	0.91B	0.91B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.89B
Shares Outstanding (Diluted Average) (Quarter)	0.91B	0.91B	0.91B	0.91B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B	0.90B
EBITDA (Quarter)	1.45B	2.06B	2.35B	2.57B	1.65B	1.74B	2.08B	1.60B	2.22B	3.43B	3.01B	2.62B	3.87B	4.35B	5.34B	5.27B	7.02B	8.02B	8.90B	9.50B
Interest Expenses (Quarter)
Tax Rate (Quarter)	12.78%	10.86%	6.19%	7.34%	12.69%	7.27%	7.57%	12.08%	15.59%	113.44%	12.71%	11.56%	15.64%	38.91%	12.47%	20.17%	16.47%	22.81%	19.70%	16.43%

Research Tools

Eli Lilly Income Statement (2009-2026) | LLY

Create an account

Sign In

Reset Password